Theranostics Australia is pleased to announce that we have become the first Industry Member of the Australian Institute of Nuclear Science and Engineering (AINSE), an organisation aimed at enhancing Australia’s capability in nuclear science and engineering, by facilitating world-class research and education. For more information, visit >> ainse.edu.au
Theranostics Australia offers an innovative and targeted approach to diagnosing and treating certain cancer types. This approach, known as theranostics, featured on 9 News last night – “New ‘magic bullet’ prostate cancer therapy delivers promising results”. For more information, please visit http://theranostics.com.au.
Video Link: 9 News
This could have a really positive impact on the fight against brain cancers: http://ow.ly/BHb3309qXbk
More exciting progress in the treatment of bowel cancers: http://ow.ly/qtRn309qWYJ
We are excited to announce our move into a new purpose designed office at Richmond Quarter in East Fremantle, Western Australia. The office will house our management, marketing, data and general administration teams. For information about our services, visit >>> theranostics.com.au.
Theranostics Australia’s A/Prof Nat Lenzo will be presenting on clinical patient experience for Lutetium-177 PSMA therapy at the Eckert & Ziegler and Imaxeon “Symposium on Theranostics”, following the conclusion of the 4th Theranostics World Congress in Melbourne, VIC.